Brand-name drug · GIP and GLP-1 receptor agonist
Mounjaro (tirzepatide)
From the FDA label, read Published by PepVault
Mounjaro is Eli Lilly’s once-weekly injection of tirzepatide, a medicine that acts on two hormone receptors, GIP and GLP-1.
FDA approved it, with diet and exercise, for blood sugar control in adults and children aged 10 and older with type 2 diabetes, and to lower the risk of major heart events in adults with type 2 diabetes at high risk of them.
- Active ingredient
- Tirzepatide
- Maker
- Eli Lilly
- Class
- GIP and GLP-1 receptor agonist
- FDA application
- NDA 215866, first approved 2022
What FDA approved it for
Mounjaro is a diabetes medicine on its label; the same tirzepatide, approved for weight and for sleep apnea, is sold as Zepbound. The heart use rests on an outcomes trial in which 6,647 adults with type 2 diabetes and heart disease took Mounjaro.
From the label: 1 Indications and Usage; 6.1 Clinical Trials Experience.
How it is supplied
| Form | Doses |
|---|---|
| Single-dose pen or vial | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
| Multi-dose vial or KwikPen (4 doses) | 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg |
From the label: 3 Dosage Forms and Strengths.
The label’s dosing schedule
This is the dosing schedule as the FDA label states it. A prescriber sets the actual dose and when it changes; it is not an instruction to the reader.
Mounjaro, once a week
| Dose | When, on the label |
|---|---|
| 2.5 mg a week | At least 4 weeks |
| 5 mg a week | At least 4 weeks, if needed |
| 7.5 mg a week | At least 4 weeks, if needed |
| 10 mg a week | At least 4 weeks, if needed (top dose for children) |
| 12.5 mg a week | At least 4 weeks, if needed |
| 15 mg a week | Top dose for adults |
Mounjaro’s label sets no fixed calendar: each 2.5 mg step comes only if blood sugar needs more help, and only after at least 4 weeks on the dose before. The top is 15 mg a week for adults and 10 mg for children.
From the label: 2.1 Recommended Dosage.
How it’s taken
Mounjaro is injected once a week at any time of day, with or without meals, into the belly or thigh, or by another person into the back of the upper arm, moving the spot each time.
It comes four ways: a single-dose pen, a single-dose vial, a multi-dose vial and a KwikPen, the last two holding 4 doses each. With a vial the label calls for a new syringe and needle for every injection. Children should not inject themselves with the KwikPen.
From the label: 2.2 Important Administration Instructions; 3 Dosage Forms and Strengths.

If a dose is missed
A missed Mounjaro dose can still be given within 4 days (96 hours). After that it is skipped and the next one comes on the usual day.
The injection day can be changed if at least 3 days (72 hours) separate two doses.
From the label: 2.1 Recommended Dosage.
Storage
Single-dose pens and vials are refrigerated at 36°F to 46°F; if needed, each can spend up to 21 days in total unrefrigerated, no warmer than 86°F, and is thrown away after that.
An unopened multi-dose vial or KwikPen kept in the fridge lasts to its expiry date, but only 30 days at room temperature. Mounjaro is never frozen and stays in its carton, out of heat and light.
From the label: 16.2 Storage and Handling.
Side effects and warnings
| Reaction | Placebo | 5 mg | 10 mg | 15 mg |
|---|---|---|---|---|
| Nausea | 4 | 12 | 15 | 18 |
| Diarrhea | 9 | 12 | 13 | 17 |
| Decreased appetite | 1 | 5 | 10 | 11 |
| Vomiting | 2 | 5 | 5 | 9 |
| Constipation | 1 | 6 | 6 | 7 |
| Dyspepsia | 3 | 8 | 8 | 5 |
| Abdominal pain | 4 | 6 | 5 | 5 |
Stomach side effects of any kind rose with the dose: 37.1% at 5 mg, 39.6% at 10 mg and 43.6% at 15 mg, against 20.4% on placebo.
The boxed warning
The other warnings
The rest of the warnings: pancreatitis, low blood sugar when combined with insulin or sulfonylureas, allergic reactions, kidney injury from fluid loss, severe stomach effects, worsening eye disease in people with diabetic retinopathy, gallbladder problems and aspiration under anesthesia. A KwikPen is for one person only.
From the label: 6.1 Clinical Trials Experience; Boxed Warning; 5 Warnings and Precautions.
How Mounjaro differs from Zepbound
Mounjaro and Zepbound hold the same active ingredient, tirzepatide. What sets them apart is on their labels: what each is approved for, the forms it comes in and how high its schedule goes.
| Compared | Mounjaro | Zepbound |
|---|---|---|
| Approved for | Type 2 diabetes (adults and children 10 and up); heart risk | Weight reduction; obstructive sleep apnea with obesity |
| Forms | Single-dose pen or vial; Multi-dose vial or KwikPen | Single-dose pen or vial; Multi-dose vial or KwikPen |
| Label’s dose range | 2.5 mg to 15 mg once a week | 2.5 mg to 15 mg once a week |
| Top dose | 15 mg a week | 15 mg a week |
| Maker | Eli Lilly | Eli Lilly |
What else we have on tirzepatide
Tirzepatide on PepVault
The trials, in plain English
Brand against brand
Compound against compound
Questions about Mounjaro
What is the starting dose of Mounjaro?
The label starts Mounjaro at 2.5 mg once a week. If more blood sugar control is needed, the dose rises in 2.5 mg steps, each after at least 4 weeks on the dose before.
What is the maximum dose of Mounjaro?
The label’s maximum is 15 mg once a week for adults and 10 mg once a week for children aged 10 and older.
What if I miss a Mounjaro dose?
Take it as soon as possible within 4 days (96 hours). If more than 4 days have passed, the label says to skip it and take the next dose on the usual day.
How long can Mounjaro stay out of the fridge?
A single-dose pen or vial can be unrefrigerated, no warmer than 86°F, for up to 21 days in total. An unopened KwikPen or multi-dose vial lasts 30 days at room temperature.
Is Mounjaro the same as Zepbound?
Both are tirzepatide from Eli Lilly. Mounjaro is approved for type 2 diabetes and heart risk in type 2 diabetes; Zepbound is approved for weight and for sleep apnea with obesity.
Sources
- MOUNJARO (tirzepatide) injection, for subcutaneous use, FDA label on DailyMed (version 40, published Sep 2, 2026; read Nov 18, 2026)
- Drugs@FDA, NDA 215866 (Mounjaro, the injection; application first approved 2022)
PepVault is not affiliated with Eli Lilly. Mounjaro is a trademark of its owner.